Skip to main content
Download PDF

Correction: The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial

Trials volume 24, Article number: 187 (2023) Cite this article

The Original Article was published on 21 December 2022

Correction: Trials 23, 1041 (2022)

https://doi.org/10.1186/s13063-022-06995-2

The original publication of this article [1] contained a typo on page 2. The incorrect and correct information is shown below. The original article has been updated.

Incorrect

In males diagnosed with low- and intermediate-risk prostate cancer, the daily addition of 200 mg of phytoestrogen-rich foods to the diet for 6 weeks reduces prostate tumor proliferation compared to no addition of phytoestrogen-rich foods to the diet during the same period.

Correct

In males diagnosed with low- and intermediate-risk prostate cancer, the daily addition of phytoestrogen-rich foods (~200 mg phytoestrogens) to the diet for 6 weeks reduces prostate tumor proliferation compared to no addition of phytoestrogen-rich foods to the diet during the same period.

Reference

  1. Ahlin R, et al. The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial. Trials. 2022;23:1041. https://doi.org/10.1186/s13063-022-06995-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Division of Clinical Cancer Epidemiology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Box 423, 40530, Gothenburg, Sweden

    Rebecca Ahlin, Gunnar Steineck & Maria Hedelin

  2. Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Sanna Nybacka

  3. Department of Urology, Sahlgrenska Cancer Center, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Andreas Josefsson

  4. Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden

    Andreas Josefsson

  5. Department of Urology and Andrology, Institute of Surgery and Perioperative Sciences, Umeå University, Umeå, Sweden

    Andreas Josefsson

  6. Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Johan Stranne

  7. Department of Urology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden

    Johan Stranne

  8. Regional Cancer Center West, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden

    Maria Hedelin

Authors
  1. Rebecca Ahlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanna Nybacka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas Josefsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johan Stranne
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gunnar Steineck
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Hedelin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Hedelin.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ahlin, R., Nybacka, S., Josefsson, A. et al. Correction: The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial. Trials 24, 187 (2023). https://doi.org/10.1186/s13063-023-07219-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13063-023-07219-x

Trials

ISSN: 1745-6215